Starpharma Launches $32 Million Fully Underwritten Renounceable Entitlement Offer at $0.57 Per Share
Australian biotech Starpharma has opened a 57-cent shareholder rights issue seeking about $32 million, with Canaccord Genuity underwriting the raise and an oversubscription facility letting holders apply for extra shares.
Also Biotech Dispatch·tipranks.com·kalkine.com.au·Biotech Dispatch